Introduction
This ongoing multi-disciplinary research directly addresses problems arising in the diagnosis and treatment of breast cancer. Early detection of breast cancer is enhanced and unnecessary surgery avoided by diagnosing breast masses from Fine Needle Aspirates (FNA's). By using and extending results from the fields of optimization, machine learning, statistics and image processing, a software system was created that allows highly accurate diagnosis of breast FNA's even by untrained users. The system is in current use at the University of Wisconsin Hospitals. For malignant cases, treatment decisions are enhanced by accurately predicting the long term behavior of the disease. This paper summarizes our recent work in both areas of diagnosis and prognosis, with emphasis on the more difficult latter problem.
Image Processing
In previous work [12, 21] cytological features thought to be relevant to diagnosis were subjectively evaluated. In order to obtain more objective and precise measurements, a graphical interface was developed which computes nuclear features interactively. A small region of each breast FNA was digitized, resulting in a 640×400, 8-bit-per-pixel gray scale image. The image analysis program, known as Xcyt [20, 22, 23] uses a curve-fitting program to determine the boundaries of nuclei from initial dots placed near these boundaries by a mouse. A portion of one such processed image is shown in Figure 1 .
Ten features are computed for each nucleus: area, radius, perimeter, symmetry, number and size of concavities, fractal dimension (of the boundary), compactness, Figure 1 : This is a magnified image of a malignant breast FNA. The visible cell nuclei have been outlined with the help of a curve fitting program. The Xcyt system also computes various features for each nucleus and accurately diagnoses the sample. The interactive diagnosis process takes about 5 minutes per sample.
smoothness (local variation of radial segments), and texture (variance of gray levels inside the boundary). The mean value, extreme value and standard error of each of these cellular features is computed, resulting in a total of 30 real-valued features for each image.
Diagnosis
A set of 569 images was processed in the manner described above, yielding a database of 569 30-dimensional points. The classification procedure used to separate benign from malignant samples is a variant on the Multisurface Method (MSM) [10, 11] known as MSM-Tree (MSM-T) [1, 2] . This method uses a linear programming [6] model to iteratively place a series of separating planes in the feature space of the examples. If the two sets of points are linearly separable, the first plane will be placed between them. If the sets are not linearly separable, MSM-T will construct a plane which minimizes the average distance of misclassified points to the plane, thus nearly minimizing the number of misclassified points. The procedure is recursively repeated on the two newly created regions. The resulting planes can then be used in the manner of a decision tree to classify new points. MSM-T has been shown [1] to learn concepts as well or better than more traditional learning methods such as C4.5 [14, 15] and CART [4] .
Even a simple single-plane classifier can be considered as 'overtraining' in a high-dimensional space. In our case, better generalization was achieved by reducing the number of input features considered. The best results were obtained with one plane and three features: Extreme area, extreme smoothness and mean texture. Applied to all the data, the training separation was 97.3%; the predicted accuracy, estimated with cross-validation [19] , was 97.0%. This classifier was built into the Xcyt system and has achieved 100% chronological correctness on the 72 new cases diagnosed. Xcyt also uses density estimation techniques [13] to estimate the probability of malignancy for new patients.
Prognosis: Recurrence Surface Approximation
A more difficult question concerns the long-term prognosis of patients with cancer. Several researchers, beginning with Black et al [3] , have shown evidence that cellular features observed at the time of diagnosis can be used to predict whether or not the disease will recur following surgery. This problem does not fit into the usual classification paradigm; while a patient can be classified 'recur' if the disease is observed, there is no real cutoff point at which she can be considered a 'non-recur'. The data are therefore censored [9] , in that we know a Time to Recur (TTR) for only a subset of patients; for the others, we know only the time of their last check-up, or Disease Free Survival time (DFS). Traditional approaches such as Cox regression [5] group large numbers of patients together in order to predict overall survival trends. We approach the prediction of TTR as a function estimation problem, a mapping of an n-dimensional real input to a one-dimensional real output. Here, the input consists of the thirty nuclear features computed by Xcyt together with with two traditional prognostic predictors: tumor size and number of involved lymph nodes. Our solution to this estimation problem is known as the Recurrence Surface Approximation (RSA) technique. RSA uses linear programming to determine a linear combination of the input features which accurately predicts TTR. The motivation for the RSA approach is that:
• Recurrences actually took place at some point in time previous to their detection. However, the difference between the time a recurrence is detectable (actual TTR) and the time it is actually detected (observed TTR) is probably small.
• Observed DFS time is a lower bound on the recurrence time of that patient.
The
The purpose of this linear program is to learn the weight vector w and the constant term γ. These parameters determine a recurrence surface s = wx+γ, where x is the vector of measured features and s is the surface which fits the observed recurrence times. Here M is an m × n matrix of the m recurrent points, with recurrence times t. Similarly, the k non-recurrent points are collected in the matrix k × n matrix N , and their last known disease free survival times in r. The vectors y and z represent the errors for recurrent and non-recurrent points, respectively; overestimating the TTR of recurrences is considered an error, while predicting a TTR which is shorter than an observed DFS is also an error. The objective averages the errors over their respective classes. The v term, weighed by an appropriately small δ, forces underestimated recurrent points closer to the surface. (Note: e is a vector of 1's of appropriate dimension.)
As in classification, it is important to choose the right subset of features to get the best generalization. We choose an appropriate feature set in the following automatic fashion. A tuning set -one tenth of the training cases -is first set aside. The RSA linear program is then solved using all of the input features, and the resulting surface is tested on the tuning set. Features are then removed, one by one, by setting the smallest (in magnitude) element of the coefficient vector w to zero.
1 Each new problem is solved and the result tested on the tuning set, until only one feature remains.
2 Using the features 1 All feature values were previously scaled to be zero mean and unit standard deviation, so that the magnitude of the weight vector component correlates roughly with the relative importance of the corresponding feature.
2 These subsequent linear programs are easily formulated by placing explicit upper and lower bounds of zero on the appropriate elements of w. A 'hot start' can then be used to solve the new LP starting from the solution to the previous one. These solutions are found very quickly, often in one or two orders of magnitude fewer simplex iterations than the original problem.
which showed the best performance on the tuning set, we then re-optimize using all the training data (e.g., restore the tuning set). In this manner, we can use the tuning set to select the complexity of the model without paying the penalty of losing some of the training set.
The RSA procedure was fit into a cross-validation framework to evaluate its accuracy in predicting future outcomes. As is typical in the machine learning community, the cross-validation procedure is used only for estimation of performance, not for parameter choosing. Of the 569 patients from the diagnosis study, the 175 malignant cases with follow-up data (35 of which have recurred) were used. Figure 2 shows the mean generalization errors of the original RSA compared against the following prediction methods:
• Pooled RSA: This method is identical to RSA except that all the points are weighted equally in the objective function, rather than the recurrent and non-recurrent cases being averaged separately. The resulting objective function is
• Least 1-norm Error on Recurs: An obvious method for predicting recurrence is to minimize the average error on just the recurrent cases.
• Modified Back-propagation: We also evaluated an Artificial Neural Network (ANN) using a modified version of back-propagation [17] . The output unit for our ANN used the identity function as its response rather than the familiar sigmoid, allowing any realvalued output. The error function was also changed to the one-sided errors as used in the RSA; learning took place only on underestimated non-recurrent cases and overestimated recurrent cases. A tuning set was used to avoid possible overtraining.
Conclusions and Future Work
Powerful machine learning paradigms such as backpropagation are widely available in commercial systems. However, for various reasons, integration of such systems into clinical practice has been slow and uncertain. By building upon the traditional optimization technique of linear programming, we are creating techniques which train faster and yield more interpretable results, while demonstrating comparable accuracy. We hope that these systems will gain wider acceptance in the field of breast cancer diagnosis and treatment.
To accomplish this, the resulting systems must give the physician information that directly affects patient care. This has been accomplished with our diagnostic system, which is easy to use and at least as accurate as diagnosis done at specialized cancer centers (see for example the collection of studies by Frable [8] ). The ongoing prognostic prediction research is less easily evaluated but will hopefully reach the same goal. Using only information available at the time of diagnosis and surgery, we are able to generate reasonably accurate predictions specific to individual patient. Related work on prognosis using machine learning has appeared in [16, 18] .
One limitation of the described approaches is the inherent linearity of the predictive models. In order to add more predictive power to the RSA method, we are implementing extensions similar to Wolpert's Stacked Generalization [24] and Fahlman's Cascade Correlation [7] . These models will introduce non-linearity to the prediction process by training different subsets of the input data separately, and combining the resulting predictions.
